Cisatracurium Dosing Requirements in COVID-19 Compared to Non-COVID-19 Patients

Abstract

Get full access to this article

View all access options for this article.

References

WHO Guideline Review Committee . Clinical Management of severe Acute Respiratory Infection When COVID-19 Disease is Suspected. WHO Iterim Guidance; 2020; 1-19.

Shang

Pan

Yang

, et al. Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Ann Intensive Care. 2020;10(10):73-24.

Poston

Patel

Davis

. Management of critically ill adults with COVID-19. J Am Med Assoc. 2020;323(18):1839-1841.

Papazian

Forel

J-M

Gacouin

, et al. Neuromuscular blockers in early acute respiratory distress syndrome. NEJM. 2010;363(12):1107-1116.

National Heart Lung, and Blood Institute Prevention and PETAL clinical trials network . Early neuromuscular blockade in the acute respiratory distress syndrome. NEJM. 2019;380:1991-2008.

Murray

Cowen

DeBlock

, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2002;30(1):142-156.